FDA.reportPublic FDA data

Buprenorphine and Naloxone

Product NDC
62175-452
11-digit product format
621750452
Labeler code
62175
Product ID
62175-452_2f25fc02-629e-4539-82b9-f22f6937d72e
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Buprenorphine and Naloxone
Dosage form
TABLET
Route
SUBLINGUAL
Labeler
Lannett Company, Inc.
Application
ANDA205022
Marketing category
ANDA
Marketing start
2016-09-19
Substance
BUPRENORPHINE; NALOXONE
Active strength
2; .5 mg/1; mg/1
Pharmacologic classes
Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]
DEA schedule
CIII
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Buprenorphine and Naloxone
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BUPRENORPHINE2 mg/1
NALOXONE.5 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii40D3SCR4GZ, 36B82AMQ7N
Rxcui351266, 351267

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
68654759-f50b-79ef-24c5-544d94fe7d87Product name320251114
c955d208-c333-9bd7-be34-d7e12986d44eProduct name620250626
e5f98bfa-66d5-4c3a-b22d-9543d3bee304Product name120250204
caa6391e-3db3-c912-335f-61b5fc00aa12Product name920240110
08a295bb-88df-4ab0-a120-a75a789a74f1Product name120231013
65a3bc34-04ff-4cf1-aad9-c7d92a062f6dProduct name120231003
e951cdf3-f269-4d97-a7d5-c1c3d7283a7dProduct name320230313
ab841ac7-728a-4fc9-be0a-35b96cecbf39Product name420230306
100316cc-94a9-474e-97ad-9b5c6ddec605Product name520230125
f327b80c-8fa2-404b-838a-df3eec141cf2Product name120221212
d4aa2fcf-79c3-4b5f-a00e-1a8e26e00119Product name120220511
539bc5d3-546b-4af6-9c31-058ce6c459d3Product name220220210
b871fccd-1de6-4c7f-b9e5-045304641ee6Product name820220118
43b1efe2-1425-4b3e-b3a2-57d40f8478b9Product name120211026
a62a50ac-1535-4461-9768-8ae703e2e9fbProduct name120210525
31e16ab2-c562-4617-a3e8-ed285320e16eProduct name120180201
4c23a34c-e8fc-424c-8fa0-ee064ba6eaefProduct name120170706
a5920611-4285-f024-69b9-39ff338b81eaProduct name520170609
0b8c7273-1da3-495f-909a-7cf1e96d2361Product name120161212
3df867ed-9d48-45cf-bded-1394beaea0b1Product name320161206
973da5bf-b1f9-4de0-81ee-7ca066c98ca4Product name120160712
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
8a245632-e24f-4ccc-b671-995d89c96ebcProduct name120141203
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877Product name120140508
bc07ef78-e82d-0c19-31f4-31f263780582Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62175-452-32Buprenorphine and Naloxone30 in 1 BOTTLETABLET3032

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
62175-452-32EA - Each62175-45261ccbdd7-590c-4c80-bc19-e5d6638ace1c12018-10-11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
62175-452BUPRENORPHINE AND NALOXONE TABLET [LANNETT COMPANY, INC.]26Current NDC, Legacy NDC, 1 package rows20240330_14eaa94a-cc8a-4e1e-8cfb-5c976c96c606.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
351266buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual TabletPSN14eaa94a-cc8a-4e1e-8cfb-5c976c96c60632
351267buprenorphine HCl 8 MG / naloxone HCl 2 MG Sublingual TabletPSN14eaa94a-cc8a-4e1e-8cfb-5c976c96c60632
351266buprenorphine 2 MG / naloxone 0.5 MG Sublingual TabletSCD14eaa94a-cc8a-4e1e-8cfb-5c976c96c60632
351267buprenorphine 8 MG / naloxone 2 MG Sublingual TabletSCD14eaa94a-cc8a-4e1e-8cfb-5c976c96c60632
351266buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual TabletSY14eaa94a-cc8a-4e1e-8cfb-5c976c96c60632
351267buprenorphine 8 MG (as buprenorphine HCl) / naloxone 2 MG (as naloxone HCl) Sublingual TabletSY14eaa94a-cc8a-4e1e-8cfb-5c976c96c60632
351266buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual TabletPSNfc2755a5-3292-4b49-872d-e22c386a4e445
351266buprenorphine 2 MG / naloxone 0.5 MG Sublingual TabletSCDfc2755a5-3292-4b49-872d-e22c386a4e445
351266buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual TabletSYfc2755a5-3292-4b49-872d-e22c386a4e445

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
62175-452-326217504523230 TABLET in 1 BOTTLE (62175-452-32) 30 tablet2016-09-190000-00-00NoNoCurrent